Cargando…
The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers
PURPOSE: Sodium-glucose co-transporter-2 inhibitor (SGLT-2i) administration is associated with some concerns in regard to the increased risk of genital and urinary tract infections (UTI) in kidney transplant recipients (KTR). In this study, we present the results of SGLT-2i use in KTR, including the...
Autores principales: | Demir, Mehmet Emin, Özler, Tuba Elif, Merhametsiz, Özgür, Sözener, Ulaş, Uyar, Murathan, Ercan, Zafer, Bardak Demir, Simge, Sezer, Siren, Türkmen Sarıyıldız, Gülçin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248967/ https://www.ncbi.nlm.nih.gov/pubmed/37289399 http://dx.doi.org/10.1007/s11255-023-03645-7 |
Ejemplares similares
-
Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients
por: Demir, Canan, et al.
Publicado: (2023) -
The Evaluation of Serum Endocan, Interleukin-6, and CRP Levels Following Sleeve Gastrectomy
por: Turkmen Sariyildiz, Gulcin, et al.
Publicado: (2023) -
Optimal use of SGLT2 inhibitors in diabetic kidney transplant recipients
por: Pham, Phuong-Thu T., et al.
Publicado: (2022) -
SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist
por: Granata, Antonio, et al.
Publicado: (2022) -
Crohnic Kidney Disease: Recurrent Acute Kidney Failure in a Patient With Crohn's Disease
por: Demir, Mehmet Emin, et al.
Publicado: (2014)